Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Subtype-specific responses of hKv7.4 and hKv7.5 channels to polyunsaturated fatty acids reveal an unconventional modulatory site and mechanism.
Frampton DJA
,
Choudhury K
,
Nikesjö J
,
Delemotte L
,
Liin SI
.
???displayArticle.abstract???
The KV7.4 and KV7.5 subtypes of voltage-gated potassium channels play a role in important physiological processes such as sound amplification in the cochlea and adjusting vascular smooth muscle tone. Therefore, the mechanisms that regulate KV7.4 and KV7.5 channel function are of interest. Here, we study the effect of polyunsaturated fatty acids (PUFAs) on human KV7.4 and KV7.5 channels expressed in Xenopus oocytes. We report that PUFAs facilitate activation of hKV7.5 by shifting the V50 of the conductance versus voltage (G(V)) curve toward more negative voltages. This response depends on the head group charge, as an uncharged PUFA analogue has no effect and a positively charged PUFA analogue induces positive V50 shifts. In contrast, PUFAs inhibit activation of hKV7.4 by shifting V50 toward more positive voltages. No effect on V50 of hKV7.4 is observed by an uncharged or a positively charged PUFA analogue. Thus, the hKV7.5 channel's response to PUFAs is analogous to the one previously observed in hKV7.1-7.3 channels, whereas the hKV7.4 channel response is opposite, revealing subtype-specific responses to PUFAs. We identify a unique inner PUFA interaction site in the voltage-sensing domain of hKV7.4 underlying the PUFA response, revealing an unconventional mechanism of modulation of hKV7.4 by PUFAs.
Figure 1. Docosahexaenoic acid facilitates the activation of hKV7.5 but inhibits the activation of hKV7.4.
(A) Molecular structure of DHA. (B) Representative current family with corresponding G(V) curve of hKV7.5 in the absence (left) and presence (middle) of 70 µM DHA. Currents generated by the voltage protocol shown as inset. Red traces denote current generated by a test voltage to –40 mV. The G(V) curves (right) have been normalized between 0 and 1, as described in Materials and methods, to better visualize shifts in V50. Curves represent Boltzmann fits (see Materials and methods for details). V50 for this specific cell: V50,ctrl = –41.7 mV, V50,DHA = –59 mV. (C) Same as in B but for hKV7.4. Blue traces denote current generated by a test voltage to 0 mV. V50 for this specific cell: V50,ctrl = –12.6 mV, V50,DHA = –2.0 mV. (D–E) Concentration-response curve of the DHA effect on V50 of hKV7.5 (D) and hKV7.4 (E). Curves represent concentration-response fits (see Materials and methods for details). Best fits: ΔV50,max is –25.3 mV for hKV7.5 and +13.8 mV for hKV7.4. EC50 is 12 µM for hKV7.5 and 14 µM for hKV7.4. Data shown as mean ± SEM. n = 3–15. See also Figure 1—figure supplement 1, Figure 1—source data 1.
Figure 2. The DHA response has a rapid onset for both hKV7.5 and hKV7.4.
Representative data showing wash-in and wash-out of 70 µM DHA on hKV7.5 (A) and hKV7.4 (B) for one oocyte each. Data points represent the current amplitude recorded following a test voltage to –40 mV (for hKV7.5) or +20 mV (for hKV7.4). The onset of DHA-induced activation of the hKV7.5 channel was quick, reaching a stable level of enhanced current within 5 min. Neither standard recording solution nor recording solution supplemented with BSA completely removed the DHA effect, and the enhanced current amplitude remained at almost threefold that of the baseline current amplitude. The onset of DHA-induced inhibition of the hKV7.4 channel was also quick, reaching a stable level of reduced current amplitude within 4.5 min. While not fully reversible, the DHA effect was reduced following re-perfusion with standard recording solution. Recording solution supplemented with 100 mg/mL BSA also reduced the inhibitory effect, with the current amplitude reaching approximately 89% of baseline current amplitude. Related to Figure 1.
AbuMweis,
Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials.
2018, Pubmed
AbuMweis,
Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials.
2018,
Pubmed
Bang,
The composition of the Eskimo food in north western Greenland.
1980,
Pubmed
Barhanin,
K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current.
1996,
Pubmed
,
Xenbase
Bercea,
Omega-3 polyunsaturated fatty acids and hypertension: a review of vasodilatory mechanisms of docosahexaenoic acid and eicosapentaenoic acid.
2021,
Pubmed
Biervert,
A potassium channel mutation in neonatal human epilepsy.
1998,
Pubmed
,
Xenbase
Bohannon,
ω-6 and ω-9 polyunsaturated fatty acids with double bonds near the carboxyl head have the highest affinity and largest effects on the cardiac IKs potassium channel.
2019,
Pubmed
,
Xenbase
Brewer,
Structures Illuminate Cardiac Ion Channel Functions in Health and in Long QT Syndrome.
2020,
Pubmed
Brueggemann,
Diclofenac distinguishes among homomeric and heteromeric potassium channels composed of KCNQ4 and KCNQ5 subunits.
2011,
Pubmed
Bussi,
Canonical sampling through velocity rescaling.
2007,
Pubmed
Börjesson,
Lipoelectric modification of ion channel voltage gating by polyunsaturated fatty acids.
2008,
Pubmed
,
Xenbase
Börjesson,
Electrostatic tuning of cellular excitability.
2010,
Pubmed
,
Xenbase
Börjesson,
An electrostatic potassium channel opener targeting the final voltage sensor transition.
2011,
Pubmed
,
Xenbase
Curhan,
Fish and fatty acid consumption and the risk of hearing loss in women.
2014,
Pubmed
Dullemeijer,
Plasma very long-chain n-3 polyunsaturated fatty acids and age-related hearing loss in older adults.
2010,
Pubmed
Engler,
Mechanisms of vasorelaxation induced by eicosapentaenoic acid (20:5n-3) in WKY rat aorta.
2000,
Pubmed
Fidzinski,
KCNQ5 K(+) channels control hippocampal synaptic inhibition and fast network oscillations.
2015,
Pubmed
Fiser,
Modeling of loops in protein structures.
2000,
Pubmed
Gao,
Impaired surface expression and conductance of the KCNQ4 channel lead to sensorineural hearing loss.
2013,
Pubmed
Gopinath,
Consumption of omega-3 fatty acids and fish and risk of age-related hearing loss.
2010,
Pubmed
Hamilton,
Fatty acid transport: difficult or easy?
1998,
Pubmed
Hoshi,
Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca²⁺-dependent K⁺ channels.
2013,
Pubmed
Humphrey,
VMD: visual molecular dynamics.
1996,
Pubmed
Jepps,
Fundamental role for the KCNE4 ancillary subunit in Kv7.4 regulation of arterial tone.
2015,
Pubmed
Jung,
Rare KCNQ4 variants found in public databases underlie impaired channel activity that may contribute to hearing impairment.
2019,
Pubmed
Kagawa,
Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases.
1982,
Pubmed
Kharkovets,
KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway.
2000,
Pubmed
Kharkovets,
Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness.
2006,
Pubmed
Kim,
Cellular and molecular mechanisms of autosomal dominant form of progressive hearing loss, DFNA2.
2011,
Pubmed
Kim,
Phosphatidylserine in the brain: metabolism and function.
2014,
Pubmed
Kubisch,
KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness.
1999,
Pubmed
,
Xenbase
Larsson,
KCNE1 tunes the sensitivity of KV7.1 to polyunsaturated fatty acids by moving turret residues close to the binding site.
2018,
Pubmed
,
Xenbase
Larsson,
Polyunsaturated Fatty Acids as Modulators of KV7 Channels.
2020,
Pubmed
Li,
Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs.
2021,
Pubmed
Liin,
Polyunsaturated fatty acid analogs act antiarrhythmically on the cardiac IKs channel.
2015,
Pubmed
,
Xenbase
Liin,
Polyunsaturated fatty acids are potent openers of human M-channels expressed in Xenopus laevis oocytes.
2016,
Pubmed
,
Xenbase
Liin,
Mechanisms Underlying the Dual Effect of Polyunsaturated Fatty Acid Analogs on Kv7.1.
2018,
Pubmed
,
Xenbase
Limbu,
Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries.
2018,
Pubmed
Mani,
Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm.
2013,
Pubmed
Martín,
Arachidonic acid effect on the allosteric gating mechanism of BK (Slo1) channels associated with the β1 subunit.
2021,
Pubmed
Massaro,
Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease.
2008,
Pubmed
Miceli,
Pharmacological Targeting of Neuronal Kv7.2/3 Channels: A Focus on Chemotypes and Receptor Sites.
2018,
Pubmed
Miller,
Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials.
2014,
Pubmed
Nappi,
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction.
2020,
Pubmed
Ng,
Expression and function of the K+ channel KCNQ genes in human arteries.
2011,
Pubmed
Qi,
CHARMM-GUI Martini Maker for Coarse-Grained Simulations with the Martini Force Field.
2015,
Pubmed
Rim,
Activation of KCNQ4 as a Therapeutic Strategy to Treat Hearing Loss.
2021,
Pubmed
Sanguinetti,
Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.
1996,
Pubmed
,
Xenbase
Saravanan,
Cardiovascular effects of marine omega-3 fatty acids.
2010,
Pubmed
Schroeder,
KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents.
2000,
Pubmed
Song,
PyLipID: A Python Package for Analysis of Protein-Lipid Interactions from Molecular Dynamics Simulations.
2022,
Pubmed
Stott,
K(V)7 potassium channels: a new therapeutic target in smooth muscle disorders.
2014,
Pubmed
Sun,
Structural Basis of Human KCNQ1 Modulation and Gating.
2020,
Pubmed
Taylor,
Regulation of KCNQ/Kv7 family voltage-gated K+ channels by lipids.
2017,
Pubmed
Tester,
Genetics of long QT syndrome.
2014,
Pubmed
Tomasello,
The Protein Imager: a full-featured online molecular viewer interface with server-side HQ-rendering capabilities.
2020,
Pubmed
Tzingounis,
The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus.
2010,
Pubmed
,
Xenbase
Vanoye,
Distinct subdomains of the KCNQ1 S6 segment determine channel modulation by different KCNE subunits.
2009,
Pubmed
Wang,
KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.
1998,
Pubmed
,
Xenbase
Wu,
Insights into Cardiac IKs (KCNQ1/KCNE1) Channels Regulation.
2020,
Pubmed
Yazdi,
Identification of PUFA interaction sites on the cardiac potassium channel KCNQ1.
2021,
Pubmed
,
Xenbase